Skip to main content Scroll Top

News

  • Home
  • Alzheimer
  • A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance
Most Viewed Posts
Clear Filters
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
2 July 2019
Boost Invest MedVallée: a decisive springboard for Montpellier’s global healthcare startups
Boost Invest MedVallée: a decisive springboard for Montpellier’s global healthcare startups
3 February 2025
Light-neuron interaction – from photobiomodulation to optical heating
9 September 2021
1 November 2022

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Read the article

Blivet G, Relano-Gines A, Wachtel M, Touchon J.

J Alzheimers Dis. 2022;90(2):811-822. doi: 10.3233/JAD-220467.

PMID: 36189591 Clinical Trial.

Share this article

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.